RIDA®PRECISION pharmacogenetic tests

Pharmacogenomics combines pharmacology and genomics to develop effective and safe drugs that will be tailored to a persons genetic constitution. Currently many drugs that are available are “one size fits all”, it is difficult to predict who will benefit from a medication, who will experience side effects and who will not respond at all.

The RIDA®PRECISION ABCB1 gene test analyses specific gene variants to predict which medication will be effective for a particular person and help to prevent adverse drug reactions.

RIDA®PRECISION ABCB1 - the gene test to optimize depression treatment

Depression is one of the most serious mental disorders being estimated to affect about 350 million people worldwide. The RIDA®PRECISION ABCB1 test predicts which antidepressants are best suited for the individual patient.

Start typing and press Enter to search